Optical biometry is the most precise

Article

Optical biometry provides more repeatable and precise measurements of biometric parameters in highly myopic eyes, states a recent study.

Optical biometry provides more repeatable and precise measurements of biometric parameters in highly myopic eyes, states a recent study.

Dr Peiyang Shen et al., Division of Preventive Ophthalmology, Zhongshan Ophthalmic Center, Guangzhou, China, compiled a comparative evaluation on optical biometry (OLCR), partial coherence interferometry (PCI) applanation ultrasound biometry in highly myopic eyes.

Biometric measurements were recorded in patients with a spherical equivalence (SE) of -6.00 D or higher and an axial length (AL) of more than 25.0 mm. OLCRS was used to obtain AL and anterior chamber depth (ACD) and compared to the results obtained using PCI and applanation A-scan ultrasound. Bland-Altman analyses were used to evaluate repeatability.

The coefficient of variations (CoVs) for OLCR, PCI and applanation ultrasound were 0.06%, 0.07%, and 0.20%, respectively. ACD was recorded at 0.29 mm, 0.53 mm and 0.51 mm, respectively. Mean radius of corneal curvature was the most similar between OLCR and PCI, with a limit of agreement of 0.12 mm.

The AL and ACD measurements obtained by optical biometry were more precise and repeatable, compared to measurements obtained from applanation biometry.

The abstract can be viewed in the latest issue of the Journal of Cataract and Refractive Surgery.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.